Christopher Garabedian Net Worth & Insider Trades
Christopher Garabedian - President and CEO, Sarepta Therapeutics, Inc
What is Christopher Garabedian's Net Worth?
The current estimated net worth of Sarepta Therapeutics, Inc's President and CEO, Christopher Garabedian, is estimated to be about $4.28M . Christopher Garabedian owns about 29,552 units of Sarepta Therapeutics, Inc common stock. In the last year at Sarepta Therapeutics, Inc, Christopher Garabedian has sold an estimated value of $0 worth.
What is Christopher Garabedian's Past Insider Trading?
Christopher Garabedian's largest purchase order was 800 units , worth over $9.45K on March 3, 2015. In total, Christopher Garabedian has made about 2 transactions over a year of their time at Sarepta Therapeutics, Inc. Christopher Garabedian usually trades in March, with the busiest year in 2014 and 2015.
Christopher Garabedian
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Christopher Garabedian's' Mailing Address?
- Mailing address is 333 River Street #303 Hoboken NJ 07030 NJ
Sarepta Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|
| Douglas S. Ingram | 2020 | $669,250 | - | $17,222 | $17,222 | $17,222 | $1,291,947 |
| Douglas S. Ingram | 2019 | $650,000 | - | $5,822 | $5,822 | $5,822 | $1,387,072 |
| Douglas S. Ingram | 2018 | $650,000 | - | $5,822 | $5,822 | $5,822 | $1,433,872 |
| Ian M. Estepan | 2020 | $445,822 | $434,986 | $32,744 | $32,744 | $32,744 | $5,177,681 |
| Ian M. Estepan | 2019 | - | - | - | - | - | - |
| Ian M. Estepan | 2018 | - | - | - | - | - | - |
| Gilmore O'Neill, M.B., M.M.Sc. | 2020 | $583,277 | $766,949 | $15,500 | $15,500 | $15,500 | $3,790,049 |
| Gilmore O'Neill, M.B., M.M.Sc. | 2019 | $563,962 | - | $15,300 | $15,300 | $15,300 | $5,168,110 |
| Gilmore O'Neill, M.B., M.M.Sc. | 2018 | $310,962 | $1,154,760 | $2,050 | $2,050 | $2,050 | $6,449,176 |
| William Ciambrone | 2020 | $458,179 | - | $14,500 | $14,500 | $14,500 | $679,938 |
| William Ciambrone | 2019 | $51,346 | - | $1,000 | $1,000 | $1,000 | $4,345,194 |
| William Ciambrone | 2018 | - | - | - | - | - | - |
| Louise Rodino-Klapac, Ph.D. | 2020 | $495,590 | $766,949 | $13,532 | $13,532 | $13,532 | $7,269,509 |
| Louise Rodino-Klapac, Ph.D. | 2019 | - | - | - | - | - | - |
| Louise Rodino-Klapac, Ph.D. | 2018 | - | - | - | - | - | - |
| Joseph Bratica | 2020 | $326,028 | $237,525 | $11,645 | $11,645 | $11,645 | $911,887 |
| Joseph Bratica | 2019 | - | - | - | - | - | - |
| Joseph Bratica | 2018 | - | - | - | - | - | - |
| Sandesh Mahatme | 2020 | $312,835 | $766,949 | $39,413 | $39,413 | $39,413 | $3,364,021 |
| Sandesh Mahatme | 2019 | $557,327 | - | $14,840 | $14,840 | $14,840 | $5,161,209 |
| Sandesh Mahatme | 2018 | $498,112 | - | $24,838 | $24,838 | $24,838 | $4,219,084 |
| David Tyronne Howton, Jr. | 2020 | $470,695 | $1,050,929 | $157,280 | $157,280 | $157,280 | $5,703,078 |
| David Tyronne Howton, Jr. | 2019 | $458,844 | - | $13,318 | $13,318 | $13,318 | $4,196,622 |
| David Tyronne Howton, Jr. | 2018 | $438,185 | - | $13,118 | $13,118 | $13,118 | $3,129,375 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/873303/000156459021019631/srpt-def14a_20210603.htm
What are Sarepta Therapeutics, Inc's Past Insider Trades?
Sarepta Therapeutics, Inc's most recent insider trade came on November 21, 2022 by Stephen Mayo who sold 858 units worth $94.31K . In the last 10 years, insiders at Sarepta Therapeutics, Inc have sold an estimated value of $177.44M and bought an estimated value of $53.33M worth of shares. Insider trading is most common in March, with the busiest year in 2017. The most active traders at the company are Sandesh Mahatme, EVP, David T Howton, EVP, and Edward M. Kaye, Director .
Sarepta Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||